Your SSRI May Not Exist Abroad: Brand Names, Approvals and Gaps by Country

The SSRI you take at home may be sold under a different name, require a new prescription, or not be approved at all in your destination country.

Your SSRI may not exist abroad: what you need to know

Fluoxetine is sold as Prozac in most English-speaking markets, but in Japan it is not approved for depression at all.^[1] That single regulatory gap catches hundreds of travellers off guard every year. The problem is not that SSRIs are rare or controlled: it is that each country's medicines regulator approves each molecule independently, and the brand names rarely match.This guide covers SSRI brand names, approval status, and prescription portability by country. For permit and customs-control rules — particularly in Gulf states — see our antidepressants and Gulf customs guide. For SNRI-specific withdrawal and dose-timing concerns, see our SNRI withdrawal guide.

Medical disclaimer: This article does not constitute medical advice. Regulations and drug approvals change. Verify current import rules and approval status with your prescriber and the destination country's medicines regulator before you travel.

Why the same molecule has different names in different countries

Every SSRI has one international nonproprietary name (INN) assigned by the WHO, and then dozens of brand names layered on top by local manufacturers and licensing deals.^[2] A pharmacist in Vietnam may not recognise "Lexapro" but will immediately know "escitalopram". Carrying the INN, not just the brand name, is the single most practical step you can take before you travel.

The INN for the most common SSRIs are: fluoxetine, sertraline, escitalopram, citalopram, paroxetine, and fluvoxamine. Keep these names on your person and in your medication passport.

Country-by-country: what is approved, what is missing, and what is renamed

Japan

Fluoxetine (Prozac) is not approved for any indication in Japan — Pfizer withdrew it after disappointing Japanese clinical trials, and it has not been re-submitted. A Japanese psychiatrist cannot prescribe fluoxetine for depression, OCD, or bulimia. Travellers may carry up to a one-month personal supply with a doctor’s letter; above one month requires a Yunyu Kakunin-sho (import certificate). Paroxetine (Paxil), sertraline (Zoloft, sometimes written J Zoloft locally), and fluvoxamine (Depromel) are approved and available. Escitalopram is approved in Japan as Lexapro with a narrower age range than in many other markets.

South Korea

South Korea’s Ministry of Food and Drug Safety (MFDS) approves all six major SSRIs. Sertraline is dispensed as Zoloft (Pfizer) and various Korean-manufactured generics. Escitalopram is sold as Lexapro and also widely as Korean-manufactured generics. The practical complication here is prescription transfer: a foreign prescription is not directly honoured at a Korean pharmacy. You need a local psychiatrist’s prescription, which typically costs ₩30,000 to ₩80,000 (~$22 to ~$59) for a private consultation.

Thailand

All major SSRIs are approved and available in Thailand, predominantly under their international brand names or Thai-manufactured generics. Fluoxetine (Prozac) is widely stocked; sertraline (Zoloft) and escitalopram (Lexapro) are available at private hospitals in Bangkok and Chiang Mai. Crucially, SSRIs require a prescription at Thai pharmacies. A private psychiatrist consultation in Bangkok costs approximately ฿1,500 to ฿3,000 (~$41 to ~$83). Paroxetine generics can be difficult to source outside major cities.

Indonesia

BPOM, Indonesia's national pharmaceutical regulator, has approved fluoxetine, sertraline, and escitalopram.^[5] Paroxetine is approved but supply outside Jakarta and Bali is unreliable. Fluvoxamine availability is limited. Indonesian pharmacies dispense SSRIs only on a local prescription, and psychiatric care outside major cities is sparse. Carry at minimum your full trip supply plus a two-week buffer.

France, Spain, and Portugal (EU/EEA)

EU centralised marketing authorisations mean that all major SSRIs are approved across France, Spain, and Portugal under the same INNs.^[6] Brand names differ: escitalopram is Cipralex in France and Germany, not Lexapro. Sertraline is Zoloft in Spain, but also widely dispensed as a generic. In France, SSRIs are reimbursed at 65% under Assurance Maladie for residents, but a visiting traveller without an EHIC/GHIC will pay full price: typically €25 to €45 (~$29 to ~$53) per box.

If you hold a valid EHIC or GHIC, you can access state healthcare in EU countries under reciprocal terms. That does not guarantee your exact brand will be stocked at a local pharmacy, but the molecule will be available.

Morocco

Morocco approves sertraline, escitalopram, and fluoxetine. Paroxetine is approved but supply in cities outside Casablanca and Rabat is inconsistent. Local generic escitalopram is widely available at Moroccan pharmacies, typically priced 45 to 90 MAD (~$4.50 to ~$9 / ~€4 to ~€8) per pack. Prescription rules apply, and supply of newer SSRIs or branded originator products is less reliable. Bring your full supply.

Mexico

COFEPRIS approves all six major SSRIs. In Mexico City and Monterrey, escitalopram (Lexapro) and sertraline (Altruline, the local brand) are consistently stocked at major pharmacy chains including Farmacias del Ahorro and Farmacias Similares. Fluoxetine generics are among the cheapest in Latin America, often under MXN 80 (~$4 / ~€3.60) per month. A private psychiatrist consultation for a prescription runs MXN 700 to MXN 1,800 (~$35 to ~$90 / ~€32 to ~€82).

The three failure points that cause travellers to run out

The brand-name problem. Asking for "Lexapro" at a German pharmacy will get you a blank look. Cipralex is the same molecule. Carry the INN, the dose, and the manufacturer country as a minimum.

The prescription transfer problem. Most countries will not honour a foreign prescription at a retail pharmacy. You either bring your full supply or you see a local doctor. A local prescription often requires an in-person psychiatric assessment, which can take days to arrange.

The abrupt discontinuation problem. SSRIs with short half-lives, particularly paroxetine, produce discontinuation symptoms within 24 to 48 hours of a missed dose. Running out mid-trip is not just inconvenient: dizziness, nausea, and mood instability can impair your ability to travel safely. This is the medical argument for carrying a two-week buffer above your expected supply. (For the SNRI version of this problem — venlafaxine has an even shorter half-life than paroxetine — see our SNRI withdrawal guide.)

What to carry with you, by document type

A doctor's letter on headed paper. This should state the INN, dose, frequency, your name, and the prescribing doctor's licence number. In countries with strict import rules, this doubles as a declaration of medical necessity.

Original pharmacy packaging. Blister packs with the pharmacist's label confirm the dispensed dose and tie the medication to your name. Decanted loose pills in an unmarked container raise questions at customs in any country.

An International Patient Summary (IPS). An IPS document stores your current medications, allergies, and diagnoses in a standardised format readable by clinicians globally. If you need a replacement prescription from a local psychiatrist abroad, they can confirm your treatment history from a single document rather than relying on a verbal history through a language barrier.

Heat, jet lag, and timing: the pharmacology issues that don't appear in the leaflet

SSRIs do not require refrigeration, but sustained heat above 30°C can degrade some formulations.^[8] Store medication in your carry-on bag rather than checked luggage, which can reach extreme temperatures in the hold. Keep packets away from direct sunlight.

Jet lag creates a timing question for once-daily SSRIs. The clinical consensus is to shift your dose time gradually toward your new local time, by about one hour per day, rather than making an abrupt switch on day one. Discuss the approach with your prescriber before you travel, particularly for paroxetine.

A quick-reference table by SSRI and key destination

Fluoxetine: approved in most countries, not approved for depression in Japan, widely available as a generic in Mexico, Morocco, and Southeast Asia.

Sertraline: the most consistently available SSRI globally. Local brand names include Altruline (Mexico, Pfizer), Zoloft / J Zoloft (Japan, Pfizer), Lustral (UK / Ireland / Spain, Pfizer). Generic supply is reliable across EU, Southeast Asia, and Latin America.

Escitalopram: sold as Cipralex in Germany, Austria, Switzerland, and France; as Lexapro in Japan, South Korea, and the US. Generic availability is strong in India, Brazil, and the EU.

Paroxetine: approved widely but supply outside major cities is inconsistent in Indonesia, Morocco, and sub-Saharan Africa. Discontinuation risk makes supply gaps particularly problematic.

Citalopram: approved across the EU, UK, North America, and Australia. Less consistently available in the Middle East and parts of Asia. Citalopram is classified as a Controlled Drug Class B (CD-B) in the UAE and requires an import permit before travel — applications moved from MOHAP to the Emirates Drug Establishment (EDE) at ede.gov.ae effective 29 December 2025.

Fluvoxamine: primarily prescribed for OCD rather than depression in many markets. Availability in Latin America and Southeast Asia is limited outside major urban centres.

Before you fly: a five-point checklist

Confirm your molecule's approval status in your destination country. Your prescriber or a travel medicine clinic can verify this.

Calculate your supply. Trip duration plus 14 days. Keep it in original packaging.

Get a doctor's letter. It should include the INN, your dose, and the prescriber's registration number.

Note the local brand name. Searching the destination country's regulator website for your INN takes under five minutes and can save hours of confusion at a foreign pharmacy.

Create an IPS record. Storing your current medications in an International Patient Summary means any clinician anywhere can see exactly what you take, at what dose, with no translation error.

Frequently asked questions

Can I use my home prescription to buy SSRIs at a pharmacy abroad?

In most countries you cannot present a foreign prescription directly at a retail pharmacy. You either bring a sufficient supply from home or obtain a local prescription from a doctor in the destination country. EU member states have limited cross-border prescription recognition under EU Directive 2011/24/EU, but implementation varies by country.

What is the difference between Lexapro and Cipralex?

Both contain escitalopram at identical doses and are therapeutically equivalent. Lexapro is the brand name used in the United States, Japan, and South Korea; Cipralex is the brand used across most of Europe. If you ask for Lexapro at a German pharmacy, ask for Cipralex instead.

How much SSRI medication should I pack for a long trip?

Pack your expected usage plus a 14-day buffer to cover lost luggage, delays, or difficulty sourcing a local prescription. Keep the entire supply in your carry-on bag, not checked luggage.

What happens if I miss SSRI doses while travelling?

Paroxetine and venlafaxine have short half-lives and can produce discontinuation symptoms within 24 to 48 hours of a missed dose, including dizziness, nausea, and mood changes. Fluoxetine has a much longer half-life and is more forgiving of occasional missed doses. If you run out, seek a local emergency prescription rather than stopping abruptly.

Which SSRI is most reliably available worldwide?

Sertraline has the widest global approval profile and generic availability. It is approved in virtually every country with a functional medicines regulator and is manufactured locally in many markets, making it the most consistently stocked SSRI at pharmacies worldwide.

What are SSRI brand names in Japan?

Paroxetine is sold as Paxil (GSK). Sertraline is sold as Zoloft, sometimes written J Zoloft (Pfizer). Fluvoxamine is sold as Depromel (Meiji Seika Pharma) — Japan was the first market to approve fluvoxamine in 1999. Escitalopram is sold as Lexapro. Fluoxetine (Prozac) is not approved or marketed in Japan at all; the manufacturer withdrew it after unsuccessful Japanese trials.